President Donald Trump recently signed an executive order aimed at expediting the review process for several psychedelic substances, including the notable compound ibogaine. This directive prompts the federal government to ease existing restrictions concerning these compounds for potential therapeutic applications.
During the signing event, Trump was accompanied by podcaster Joe Rogan. Rogan is known for his outspoken support of ibogaine, which is sourced from a West African plant and has found use among some military veteran groups as a treatment for conditions like PTSD.
Advocacy groups have long advocated for increased research into psychedelics’ potential uses for treating various ailments, such as depression. Trump emphasized that the new order could provide hope for individuals suffering from debilitating symptoms, suggesting it could have a substantial positive impact.
The push for psychedelic research has garnered bipartisan support in the U.S., given that substances like ibogaine are currently classified under the federal government’s most restrictive categories for illicit drugs.
Source: www.aljazeera.com
About the Author
